sb 203580 has been researched along with Amnionitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arici, A; Buchwalder, LF; Kayisli, UA; Kizilay, G; Lockwood, CJ; Murk, W; Oner, C; Schatz, F | 1 |
1 other study(ies) available for sb 203580 and Amnionitis
Article | Year |
---|---|
Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery.
Topics: Blotting, Western; Chorioamnionitis; Decidua; Enzyme-Linked Immunosorbent Assay; Female; Humans; Imidazoles; Immunohistochemistry; Interleukin-1beta; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Obstetric Labor, Premature; Pregnancy; Progesterone Congeners; Protein Kinase Inhibitors; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2008 |